Literature DB >> 33438107

Influence of Particle Size and Drug Load on Amorphous Solid Dispersions Containing pH-Dependent Soluble Polymers and the Weak Base Ketoconazole.

Marius Monschke1, Kevin Kayser1, Karl G Wagner2.   

Abstract

Among the great number of poorly soluble drugs in pharmaceutical development, most of them are weak bases. Typically, they readily dissolve in an acidic environment but are prone to precipitation at elevated pH. This was aimed to be counteracted by the preparation of amorphous solid dispersions (ASDs) using the pH-dependent soluble polymers methacrylic acid ethylacrylate copolymer (Eudragit L100-55) and hydroxypropylmethylcellulose acetate succinate (HPMCAS) via hot-melt extrusion. The hot-melt extruded ASDs were of amorphous nature and single phased with the presence of specific interactions between drug and polymer as revealed by X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), and Fourier-transform infrared spectroscopy (FT-IR). The ASDs were milled and classified into six particle size fractions. We investigated the influence of particle size, drug load, and polymer type on the dissolution performance. The best dissolution performance was achieved for the ASD made from Eudragit L100-55 at a drug load of 10%, whereby the dissolution rate was inversely proportional to the particle size. Within a pH-shift dissolution experiment (from pH 1 to pH 6.8), amorphous-amorphous phase separation occurred as a result of exposure to acidic medium which caused markedly reduced dissolution rates at subsequent higher pH values. Phase separation could be prevented by using enteric capsules (Vcaps Enteric®), which provided optimal dissolution profiles for the Eudragit L100-55 ASD at a drug load of 10%.

Entities:  

Keywords:  Amorphous solid dispersions; Hot-melt extrusion; Supersaturation; pH-dependent soluble polymers

Year:  2021        PMID: 33438107      PMCID: PMC7803674          DOI: 10.1208/s12249-020-01914-7

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  45 in total

1.  Inhibitory effect of hydroxypropyl methylcellulose acetate succinate on drug recrystallization from a supersaturated solution assessed using nuclear magnetic resonance measurements.

Authors:  Keisuke Ueda; Kenjirou Higashi; Keiji Yamamoto; Kunikazu Moribe
Journal:  Mol Pharm       Date:  2013-09-26       Impact factor: 4.939

Review 2.  Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.

Authors:  Chau Le-Ngoc Vo; Chulhun Park; Beom-Jin Lee
Journal:  Eur J Pharm Biopharm       Date:  2013-09-18       Impact factor: 5.571

3.  Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.

Authors:  Dajun D Sun; Ping I Lee
Journal:  Mol Pharm       Date:  2015-03-23       Impact factor: 4.939

4.  Rational development of solid dispersions via hot-melt extrusion using screening, material characterization, and numeric simulation tools.

Authors:  Damir E Zecevic; Karl G Wagner
Journal:  J Pharm Sci       Date:  2013-05-09       Impact factor: 3.534

5.  Influence of admixed citric acid on the release profile of pelanserin hydrochloride from HPMC matrix tablets.

Authors:  R Espinoza; E Hong; L Villafuerte
Journal:  Int J Pharm       Date:  2000-05-25       Impact factor: 5.875

6.  Impact of phase separation morphology on release mechanism of amorphous solid dispersions.

Authors:  Yi Rang Han; Yingshan Ma; Ping I Lee
Journal:  Eur J Pharm Sci       Date:  2019-06-12       Impact factor: 4.384

7.  Investigating miscibility and molecular mobility of nifedipine-PVP amorphous solid dispersions using solid-state NMR spectroscopy.

Authors:  Xiaoda Yuan; Diana Sperger; Eric J Munson
Journal:  Mol Pharm       Date:  2013-11-27       Impact factor: 4.939

8.  Polymer-Mediated Drug Supersaturation Controlled by Drug-Polymer Interactions Persisting in an Aqueous Environment.

Authors:  Yuejie Chen; Yipshu Pui; Huijun Chen; Shan Wang; Peter Serno; Wouter Tonnis; Linc Chen; Feng Qian
Journal:  Mol Pharm       Date:  2018-11-30       Impact factor: 4.939

9.  Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition.

Authors:  Dave A Miller; James C DiNunzio; Wei Yang; James W McGinity; Robert O Williams
Journal:  Drug Dev Ind Pharm       Date:  2008-08       Impact factor: 3.225

Review 10.  Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products.

Authors:  Palpandi Pandi; Raviteja Bulusu; Nagavendra Kommineni; Wahid Khan; Mandip Singh
Journal:  Int J Pharm       Date:  2020-06-18       Impact factor: 5.875

View more
  3 in total

1.  Optimization of Spray-Drying Parameters for Formulation Development at Preclinical Scale.

Authors:  Marika Nespi; Robert Kuhn; Chun-Wan Yen; Joseph W Lubach; Dennis Leung
Journal:  AAPS PharmSciTech       Date:  2021-12-20       Impact factor: 3.246

2.  Boost of solubility and supersaturation of celecoxib via synergistic interactions of methacrylic acid-ethyl acrylate copolymer (1:1) and hydroxypropyl cellulose in ternary amorphous solid dispersions.

Authors:  Florian Pöstges; Kevin Kayser; Edmont Stoyanov; Karl G Wagner
Journal:  Int J Pharm X       Date:  2022-03-24

3.  Downstream Processing of Itraconazole:HPMCAS Amorphous Solid Dispersion: From Hot-Melt Extrudate to Tablet Using a Quality by Design Approach.

Authors:  Saurabh M Mishra; Margarethe Richter; Luis Mejia; Andreas Sauer
Journal:  Pharmaceutics       Date:  2022-07-07       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.